October 14th 2024
The Big Pharma commercialization playbook doesn’t work for emerging life sciences companies bootstrapping their way up. Exploring three strategies that could be the ingredients of a winning formula for startups.
Miruna Sasu, Former Johnson & Johnson Executive, Takes the Helm at COTA, Inc. as President and CEO
March 24th 2022Pharma trailblazer will accelerate growth at COTA with a focus on advancing real-world data use in drug development, increasing diversity in clinical trials, and supporting the move to data-driven, value-based cancer care.
Insilico Medicine Announces Strategic Collaboration with EQRx
March 24th 2022The collaboration leverages Insilico's end-to-end AI-driven Pharma.AI platform to discover novel small molecule drug candidates for multiple targets, along with EQRx's innovative business model to accelerate drug development and patient access to novel medicines at affordable prices.
How to Make Your Meetings with HCPs More Insightful and Successful
February 28th 2022Encounters with healthcare providers (HCPs) requires diligent preparation. Beyond understanding the value of the therapies you're offering, all touchpoints and conversations are of the highest importance - through sharing research, new ideas, and how you can support HCPs, you gain valuable, relevant insights that inform your relationship with HCPs and help them blossom.
PharmaForce International: US Immunology Market Sees Significant Changes to Sales Approaches
February 14th 2022Examples of these restructurings include the shifting of product priorities, creation of new business units, consolidations of sales full-time equivalents (FTEs), adjustments of leadership positions, and layoffs. One major change, in particular, is the realignment of sales teams as a response to newly approved indications.